Related Experiment Video

Updated: Feb 25, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.7K

Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease

Kimberley A Chien1, Hoda T Hammad2, Linda Gerber1

  • 1Department of Pediatrics.

Journal of Pediatric Gastroenterology and Nutrition
|July 26, 2017
PubMed

Insights

Pediatric inflammatory bowel disease (IBD) patients face a higher risk of venous thromboembolism (VTE). However, pediatric gastroenterologists rarely use VTE prophylaxis due to a lack of specific guidelines for children.

Area of Science:

  • Pediatric gastroenterology
  • Hematology
  • Internal medicine

Background:

  • Patients with inflammatory bowel disease (IBD) have a significantly elevated risk of venous thromboembolism (VTE).
  • Established prophylaxis guidelines exist for adult IBD patients, but a consensus for pediatric IBD patients is lacking.
  • Children with IBD are also known to experience increased rates of VTE.

Purpose of the Study:

  • To assess pediatric gastroenterologists' awareness of VTE risk in children with IBD.
  • To understand current practices regarding VTE prophylaxis in pediatric IBD patients.
  • To identify barriers to implementing VTE prophylaxis in this population.

Main Methods:

  • A survey was distributed to practicing pediatric gastroenterologists.
  • The survey assessed awareness, perceived risk, and current prophylaxis practices for VTE in pediatric IBD patients.
  • Key reasons for not providing prophylaxis were investigated.

Main Results:

  • Pediatric gastroenterologists are aware of the heightened VTE risk in pediatric IBD patients.
  • Anticoagulant prophylaxis is infrequently utilized for pediatric patients with IBD.
  • The primary reason cited for the infrequent use of prophylaxis is the absence of specific literature guidelines.

Conclusions:

  • Despite awareness of increased VTE risk, current prophylaxis practices for pediatric IBD patients are limited.
  • The lack of clear, evidence-based guidelines is a significant barrier to VTE prophylaxis in this population.
  • Further research and guideline development are needed to optimize VTE prevention in children with IBD.

More Related Videos

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.7K
Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices02:14

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

1.7K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
852
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
960
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
760
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332